Compare FBYD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FBYD | SMTI |
|---|---|---|
| Founded | 2021 | 1982 |
| Country | United States | United States |
| Employees | 207 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.8M | 182.6M |
| IPO Year | N/A | 2008 |
| Metric | FBYD | SMTI |
|---|---|---|
| Price | $6.90 | $19.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 94.4K | 57.4K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $20.66 |
| Revenue Next Year | N/A | $13.97 |
| P/E Ratio | $268.88 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $3.71 | $18.29 |
| 52 Week High | $29.02 | $35.70 |
| Indicator | FBYD | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 43.21 |
| Support Level | $5.77 | $18.60 |
| Resistance Level | $7.36 | $21.18 |
| Average True Range (ATR) | 0.90 | 1.08 |
| MACD | 0.23 | 0.02 |
| Stochastic Oscillator | 63.13 | 26.19 |
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.